FDA Warning Letter — MEDVi
The FDA took a Warning Letter action against MEDVi on Feb 20, 2026 (Newark, DE). The action was issued by CDER and concerns drugs products.
Action details
- Facility
- MEDVi
- Date
- Feb 20, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Center
- CDER
- Location
- Newark, DE (United States)